AIDS

Skip Navigation LinksHome > March 27, 2012 - Volume 26 - Issue 6 > A national review of vertical HIV transmission
AIDS:
doi: 10.1097/QAD.0b013e328350995c
Epidemiology and Social

A national review of vertical HIV transmission

Forbes, John C.a; Alimenti, Ariane M.a; Singer, Joelb,f; Brophy, Jason C.c; Bitnun, Arid; Samson, Lindy M.c; Money, Deborah M.e; Lee, Terry C.K.f; Lapointe, Normand D.g; Read, Stanley E.d; the Canadian Pediatric AIDS Research Group (CPARG)

Collapse Box

Abstract

Objectives: Prevention of vertical HIV transmission has evolved significantly in Canada over the last two decades. The aim of this analysis is to describe the surveillance programme used, rate of vertical HIV transmission and changing epidemiology of HIV-affected pregnancies in Canada.

Design: National perinatal HIV surveillance programme.

Methods: From 1990, annual retrospective data was collected on demographic and clinical characteristics of HIV-infected mothers and their infants referred to 22 participating sites across Canada either before/during pregnancy or within 3 months after delivery. Factors impacting HIV transmission and demographic features were explored.

Results: Two thousand, six hundred and ninety-two mother–infant pairs were identified. The overall rate of vertical HIV transmission was 5.2%, declining to 2.9% since 1997. The rate of transmission for mothers who received HAART was 1%, and 0.4% if more than 4 weeks of HAART was given. Forty percent of women delivered by caesarean section, with no difference in transmission rate compared with vaginal delivery for women treated with HAART (1.4 vs. 0.6%, P = 0.129) but significant risk reduction for those who did not receive HAART (3.8 vs. 10.3%, P = 0.016). Black women were the largest group; proportions of black and aboriginal women increased significantly over time (P < 0.001 for both). Heterosexual contact was the most common risk category for maternal infection (65%), followed by injection drug use (IDU) (25%).

Conclusion: Vertical HIV transmission in Canada has decreased dramatically for women treated with HAART therapy. All pregnant women should be evaluated for HIV infection and programmes expanded to reach vulnerable populations including aboriginal, immigrant and IDU women.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.